Cargando…
Visceral Leishmaniasis Treatment, Italy
First-line drug treatment was recorded in 573 immunocompetent patients with visceral leishmaniasis in Italy. In the past 12 years, the proportion of antimonial treatments decreased from 100% to 2.8%, while the proportion of amphotericin B treatments increased from 0% to 97.2%. The countrywide change...
Autores principales: | Gradoni, Luigi, Gramiccia, Marina, Scalone, Aldo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034325/ https://www.ncbi.nlm.nih.gov/pubmed/14720406 http://dx.doi.org/10.3201/eid0912.030178 |
Ejemplares similares
-
Epidemiology of Imported Leishmaniasis in Italy: Implications for a European Endemic Country
por: Di Muccio, Trentina, et al.
Publicado: (2015) -
Correction: Epidemiology of Imported Leishmaniasis in Italy: Implications for a European Endemic Country
por: Di Muccio, Trentina, et al.
Publicado: (2015) -
Canine Leishmaniasis, Italy
por: Ferroglio, Ezio, et al.
Publicado: (2005) -
Asymptomatic Visceral Leishmaniasis, Northern Israel
por: Adini, Irit, et al.
Publicado: (2003) -
Visceral Leishmaniasis in Rural Bihar, India
por: Hasker, Epco, et al.
Publicado: (2012)